These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16247997)

  • 41. Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.
    Saíz-Urra L; Teijeira M; Rivero-Buceta V; Helguera AM; Celeiro M; Terán MC; Besada P; Borges F
    Mol Divers; 2016 Feb; 20(1):55-76. PubMed ID: 26205409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 3'-ureidoadenosines and their high binding affinity at the mutant A3 adenosine receptor.
    Kim AY; Kim HO; Kim MJ; Chun MW; Lee KM; Jacobson KA; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2005; (49):105-6. PubMed ID: 17150655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
    Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidimensional drug design: simultaneous analysis of binding and relative efficacy profiles of N(6)-substituted-4'-thioadenosines A3 adenosine receptor agonists.
    Cruz-Monteagudo M; Cordeiro MN; Teijeira M; González MP; Borges F
    Chem Biol Drug Des; 2010 Jun; 75(6):607-18. PubMed ID: 20408851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthetic procedure for the preparation of novel potent and selective A3 adenosine receptor radioligands.
    Volpini R; Costanzi S; Lambertucci C; Vittori S; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):775-9. PubMed ID: 11563114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N
    Yu J; Zhao LX; Park J; Lee HW; Sahu PK; Cui M; Moss SM; Hammes E; Warnick E; Gao ZG; Noh M; Choi S; Ahn HC; Choi J; Jacobson KA; Jeong LS
    J Med Chem; 2017 Apr; 60(8):3422-3437. PubMed ID: 28380296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of N6-substituted 3'-ureidoadenosine derivatives as highly potent agonists at the mutant A3 adenosine receptor.
    Jeong LS; Choe SA; Kim AY; Kim HO; Gao ZG; Jacobson KA; Chun MW; Moon HR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):717-9. PubMed ID: 18066887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles.
    Mogensen JP; Roberts SM; Bowler AN; Thomsen C; Knutsen LJ
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1767-70. PubMed ID: 9873431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and evaluation of N⁶-substituted apioadenosines as potential adenosine A₃ receptor modulators.
    Toti KS; Moss SM; Paoletta S; Gao ZG; Jacobson KA; Van Calenbergh S
    Bioorg Med Chem; 2014 Aug; 22(15):4257-68. PubMed ID: 24931275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The synthesis of a series of adenosine A3 receptor agonists.
    Broadley KJ; Burnell E; Davies RH; Lee AT; Snee S; Thomas EJ
    Org Biomol Chem; 2016 Apr; 14(15):3765-81. PubMed ID: 27001924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regio- and stereoselective synthesis of truncated 3'-aminocarbanucleosides and their binding affinity at the A3 adenosine receptor.
    Choi MJ; Chandra G; Lee HW; Hou X; Choi WJ; Phan K; Jacobson KA; Jeong LS
    Org Biomol Chem; 2011 Oct; 9(20):6955-62. PubMed ID: 21860878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
    Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
    J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.
    Van Rompaey P; Jacobson KA; Gross AS; Gao ZG; Van Calenbergh S
    Bioorg Med Chem; 2005 Feb; 13(4):973-83. PubMed ID: 15670905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity.
    Homma H; Watanabe Y; Abiru T; Murayama T; Nomura Y; Matsuda A
    J Med Chem; 1992 Jul; 35(15):2881-90. PubMed ID: 1495019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial agonists for A(3) adenosine receptors.
    Gao ZG; Jacobson KA
    Curr Top Med Chem; 2004; 4(8):855-62. PubMed ID: 15078216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography.
    Kiesewetter DO; Lang L; Ma Y; Bhattacharjee AK; Gao ZG; Joshi BV; Melman A; de Castro S; Jacobson KA
    Nucl Med Biol; 2009 Jan; 36(1):3-10. PubMed ID: 19181263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.
    Paoletta S; Tosh DK; Finley A; Gizewski ET; Moss SM; Gao ZG; Auchampach JA; Salvemini D; Jacobson KA
    J Med Chem; 2013 Jul; 56(14):5949-63. PubMed ID: 23789857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.